Search results
Results from the WOW.Com Content Network
Project MKULTRA subproject 8 on the use of LSD as a pyschochemical weapon. Psychochemical warfare involves the use of psychopharmacological agents (mind-altering drugs or chemicals) with the intention of incapacitating an adversary through the temporary induction of hallucinations or delirium.
Incapacitating agent is a chemical or biological agent which renders a person unable to harm themselves or others, regardless of consciousness. [ 1 ] Lethal agents are primarily intended to kill, but incapacitating agents can also kill if administered in a potent enough dose, or in certain scenarios.
Suspended in Europe Increased risk of skin cancers. [26] [27] Iodinated casein strophantin: 1964 US Metabolic reaction. [3] Iproniazid: 1964 Canada Interactions with food products containing tyrosine. [28] Isaxonine phosphate: 1984 France Hepatotoxicity. [3] Isoxicam: 1983 France, Germany, Spain, others Stevens–Johnson syndrome. [3] Kava Kava ...
The following are settlements reached with US authorities against pharmaceutical companies to resolve allegations of "off-label" promotion of drugs. Under the Federal Food, Drug, and Cosmetic Act, it is illegal for pharmaceutical companies to promote their products for uses not approved by the Food and Drug Administration (FDA), and corporations that market drugs for off-label indications may ...
U.S. attorneys have responded in court to claims from Sean "Diddy" Combs' lawyers that government agents leaked information, including footage of Combs physically assaulting his ex-girlfriend ...
A Pennsylvania health care system this month agreed to pay $65 million to victims of a February 2023 ransomware attack after hackers posted nude photos of cancer patients online, according to the ...
A man has been arrested over the leak of graphic crime scene photos taken from the wooded trail where teenage best friends Libby German and Abby Williams were brutally murdered.. In what marks the ...
Flibanserin is the first pharmaceutical product from Sprout Pharmaceuticals [14] for premenopausal women with HSDD. The drug was approved by the FDA in 2015. It compiles a serotonin 1A receptor agonist and a serotonin 2A receptor antagonist. [15] and is an antidepressant [16] that was originally developed for depression. [12]